Asthma News – March 31, 2023
Current asthma research, announcements and opportunities, collected and distributed by Michigan Department of Health & Human Services (MDHHS) Asthma Program Staff.
Sign up to receive weekly-ish news emails.
Check out the most recent
MDHHS asthma social media messages and share them with your networks.
EPA is requesting applications
from eligible entities to conduct demonstrations, technical assistance, training, education and/or outreach projects that seek to improve public health protection against smoke from wildfires by enhancing preparedness in community buildings.
Environmental Protection Agency (EPA): Listening Sessions for the Inflation Reduction Act’s Funding to Address Air Pollution at Schools
EPA is holding two identical listening sessions to share a high-level overview of the Funding to Address Air Pollution at Schools and to gather your input on how EPA can best address school air quality issues in low-income and disadvantaged communities with this funding.
The C.S. Mott Children’s Hospital National Poll on Children’s Health asked a sample of parents of children 11-18 years about vaping. Few parents think their children actually vape, and 4 out of 5 parents believe their preteen and teenage children are clear on the risks that electronic cigarettes pose.
For non–oral corticosteroid (OCS)-dependent patients, 53.3% achieved at least 1 background medication reduction, increasing to 72.6% for patients who maintained protocol-defined asthma control at end of trial. Of OCS-dependent patients, 50.5% eliminated OCS and 74.7% achieved dosages ≤5 mg at end of trial.
New study findings suggest that patients with atopic march should be expected to exhibit a more severe phenotype of asthma with increased asthma morbidity. Those without atopic march had a milder asthma phenotype, less need for steroids, and fewer hospital admissions, but had a higher prevalence of ear-nose-and-throat pathologies and/or gastroesophageal reflux.
Using the Mobile Airways Sentinel Network for airway diseases app, researchers developed and validated an electronic daily asthma control score (e-DASTHMA). e-DASTHMA was found to be good tool for the daily assessment of asthma control, and can be used as an endpoint in clinical trials as well as in clinical practice to assess fluctuations in asthma control and guide treatment optimisation.